Physician profile
Eric A Johnson
NPI 1659734002
$2,960.79
in general payments reported to CMS, 2019-2025
9 companies · $699 in 2025
The $699 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,619 · 2022: $254 · 2023: $232 · 2024: $157 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,464.34 | 2021-2024 | Hemosphere, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $813.88 | 2021-2025 | Corevalve Evolut R, Affera Mapping System, Artic-L 3d Ti Spinal System With Tionic Technology |
| Boston Scientific Corporation | $195.07 | 2022 | |
| Cordis US Corp. | $160.86 | 2025 | Mynx Control |
| Pacira Pharmaceuticals Incorporated | $147.37 | 2025 | Exparel |
| Philips North America LLC | $59.62 | 2024 | (Ck4) Mcot |
| Cvrx, INC. | $59.41 | 2022 | |
| Merck Sharp & Dohme LLC | $40.23 | 2023-2024 | Bridion |
| Silk Road Medical, INC. | $20.01 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.